These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11796346)

  • 1. Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin.
    Damle BD; Mummaneni V; Kaul S; Knupp C
    Antimicrob Agents Chemother; 2002 Feb; 46(2):385-91. PubMed ID: 11796346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole.
    Damle B; Hess H; Kaul S; Knupp C
    Biopharm Drug Dispos; 2002 Mar; 23(2):59-66. PubMed ID: 11932960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects.
    Damle BD; Kaul S; Behr D; Knupp C
    J Clin Pharmacol; 2002 Jul; 42(7):791-7. PubMed ID: 12092746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.
    la Porte C; Verweij-van Wissen C; van Ewijk N; Aarnoutse R; Koopmans P; Reiss P; Stek M; Hekster Y; Burger D
    J Clin Pharmacol; 2005 Feb; 45(2):211-8. PubMed ID: 15647414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of didanosine formulations on the pharmacokinetics of amprenavir.
    Shelton MJ; Giovanniello AA; Cloen D; Berenson CS; Keil K; DiFrancesco R; Hewitt RG
    Pharmacotherapy; 2003 Jul; 23(7):835-42. PubMed ID: 12885096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
    Purkins L; Wood N; Kleinermans D; Love ER
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):62-8. PubMed ID: 14616416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.
    Damle B; Ullah I; Doll W; Wiley G; Knupp C
    Br J Clin Pharmacol; 2002 Sep; 54(3):255-61. PubMed ID: 12236845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir.
    Sturgill MG; Seibold JR; Boruchoff SE; Yeh KC; Haddix H; Deutsch P
    J Clin Pharmacol; 1999 Oct; 39(10):1077-84. PubMed ID: 10516943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers.
    Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N
    Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
    Kays MB; Overholser BR; Mueller BA; Moe SM; Sowinski KM
    Am J Kidney Dis; 2003 Dec; 42(6):1253-9. PubMed ID: 14655198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
    De Wit S; Debier M; De Smet M; McCrea J; Stone J; Carides A; Matthews C; Deutsch P; Clumeck N
    Antimicrob Agents Chemother; 1998 Feb; 42(2):223-7. PubMed ID: 9527763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
    Abou-Auda HS; Mustafa AA; Al-Humayyd MS
    Biopharm Drug Dispos; 2008 Jan; 29(1):29-35. PubMed ID: 17943700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If taken 1 hour before indinavir (IDV), didanosine does not affect IDV exposure, despite persistent buffering effects.
    Shelton MJ; Mei H; Hewitt RG; Defrancesco R
    Antimicrob Agents Chemother; 2001 Jan; 45(1):298-300. PubMed ID: 11120981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects.
    Abbas R; Hug BA; Leister C; Burns J; Sonnichsen D
    Br J Clin Pharmacol; 2011 Apr; 71(4):522-7. PubMed ID: 21395644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.
    Rhame FS; Rawlins SL; Petruschke RA; Erb TA; Winchell GA; Wilson HM; Edelman JM; Abramson MA
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4200-8. PubMed ID: 15504842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.